share_log

HC Wainwright & Co. Reiterates Buy on Hoth Therapeutics, Maintains $4 Price Target

Moomoo 24/7 ·  Apr 5 06:15

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment